CCRM

10/19/2026

Over at Signals, our expert explains the -winning work and how it has moved beyond .

https://www.signalsblog.ca/a-nobel-for-optogenetics-the-real-reason-behind-the-win/

10/15/2026

Quantum computing could play an increasingly important role in how we develop, manufacture and optimize advanced therapies. As the cell and gene therapy sector matures, the ability to tackle challenging problems involving biological systems, molecular interactions and bioprocessing could become increasingly valuable.

The latest episode of Commercializing Living Therapies with CCRM explores the intersection of quantum computing, artificial intelligence (AI) and advanced therapies with Alán Aspuru-Guzik, University of Toronto, Vector Institute, NVIDIA, and Martin Roetteler, IonQ.

In this episode, host Krista Lamb-Davidson and our guests examine:

🔹 How quantum computing differs from classical computing, and how it can work alongside AI
🔹 Where quantum computing could have an impact across cell and gene therapy development and manufacturing
🔹 Emerging use cases, including quantum-enhanced bioprocessing, modelling and optimization
🔹 The hurdles that need to be overcome before broader adoption
🔹 What developers and the broader life sciences community should consider as quantum technologies evolve

What happens when quantum computing meets advanced therapies? Check out our latest episode.

Listen at the link below, or find it wherever you stream podcasts.

https://www.ccrm.ca/podcast/

10/14/2026

Women are most commonly diagnosed with dysautonomia. What is it and can stem cells make a difference in treating the improper functioning of the autonomic nervous system?

On this Stem Cell Awareness Day, we explore the efficacy of treating dysautonomia with mesenchymal stem cells to reduce inflammation and overreactivity of the immune system.

https://www.signalsblog.ca/raising-awareness-of-dysautonomia-and-potential-treatments/

10/14/2026

And the winner of this year's Cells I See People's Choice Award is...Margaux Brin, CHU Sainte-Justine! "Eye of Sauron" shows a rosette-like structure revealing primary cilia emerging within its lumen.

“Eye of Sauron” received the most votes (likes) in the Cells I See album on CCRM’s page during the voting period. Thanks to everyone who voted!

Hosted by CCRM and the Stem Cell Network - Réseau de cellules souches, Cells I See celebrates the beauty of cells seen directly through the microscope or through the artist's interpretive lens. The Cells I See art contest will also award $750 to the Grand Prize winner, based on blind judging at the 2026 Till & McCulloch Meetings, taking place in Vancouver, Canada, from November 9-11.

Happy Stem Cell Awareness Day!

10/02/2026

A recent event in Toronto suggests there is optimism that can have a meaningful impact on accelerating the commercialization of cell and gene therapies.

Read our latest blog post https://signalsblog.ca/right-turn-exploring-quantum-computing-and-its-real-world-impact-for-advanced-therapies/

10/01/2026

Don't forget to vote for the Cells I See People's Choice Award by October 7, 2026.

hosted by CCRM and Stem Cell Network - Réseau de cellules souches.

09/22/2026

CCRM President and CEO Michael May was named to The Medicine Maker's Power List. Here is a short interview with him about the cell and gene therapy field.

CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy

09/18/2026

Who can we trust online when we're looking for credible health information? The latest blog post on Signals provides some guidance and helpful resources, along with relevant information for the cell and gene therapy community.

https://www.signalsblog.ca/right-turn-healthy-distractions/

09/15/2026

How can we make advanced therapies more accessible to patients around the world – not just for those in countries with the resources to support them?

In the latest episode of Commercializing Living Therapies with CCRM, host Krista Lamb is joined by Bambi Grilley, Baylor College of Medicine, and Staci Arnold, Emory University and Children's Healthcare of Atlanta, to explore the challenges and opportunities involved in the equitable deployment of cell and gene therapies (CGTs).

They cover:

🔹 The current landscape of CGT access in low- and middle-income countries

🔹 Economic, manufacturing, delivery and regulatory barriers

🔹 The potential of public-private partnerships and other access models

🔹 The role of patients and health NGOs

🔹 Why equitable access is particularly important in cancer care

🔹 What is giving experts hope for the future

As CGTs become increasingly available, ensuring that these therapies reach patients globally will require collaboration, innovation and new approaches to access.

Listen at the link below, or find it wherever you stream podcasts.

https://www.ccrm.ca/podcast/

09/09/2026

With 27 entries in this year’s Cells I See art contest, we’re pleased to announce that voting for the 2026 People’s Choice Award is now open.

Head to the Cells I See 2026 album on our page, check out all the entries, and tap “like” on your favourite photo to vote for the People's Choice Award winner. The winner will take home a $500 prize, to be awarded at the 2026 Till & McCulloch Meetings, taking place November 9-11 in Vancouver, BC. Cells I See is co-hosted with the Stem Cell Network - Réseau de cellules souches.

Voting will be available from Wednesday, September 9, to Wednesday, October 7, 2026.

Share this post to spread the word! Vote here ➡️ https://www.facebook.com/media/set/?vanity=commercializinglivingtherapies&set=a.1505532958258110